Veterinary Medicines

EXFLOW 10 MG/G POWDER FOR USE IN DRINKING WATER FOR CATTLE (CALVES), PIGS, CHICKENS, TURKEYS AND DUCKS

Not authorised
  • Bromhexine hydrochloride
Download as PDF

Product identification

Medicine name:
EXFLOW 10 MG/G POWDER FOR USE IN DRINKING WATER FOR CATTLE (CALVES), PIGS, CHICKENS, TURKEYS AND DUCKS
Exflow Vet 10 mg/g poeder voor gebruik in drinkwater voor runderen (kalveren), varkens, kippen, kalkoenen en eenden
Active substance:
  • Bromhexine hydrochloride
Target species:
  • Turkey
  • Pig
  • Cattle (calf)
  • Duck
  • Chicken (broiler)
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Bromhexine hydrochloride
    10.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Powder for use in drinking water
Withdrawal period by route of administration:
  • Oral use
    • Turkey
      • Meat and offal
        0
        day
      • Eggs
        no withdrawal period
    • Pig
      • Meat and offal
        0
        day
    • Cattle (calf)
      • Meat and offal
        2
        day
      • Milk
        no withdrawal period
    • Duck
      • Meat and offal
        0
        day
      • Eggs
        no withdrawal period
    • Chicken (broiler)
      • Meat and offal
        0
        day
      • Eggs
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QR05CB02
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Netherlands
Package description:
  • Bag of 1 kg
  • Bag of 2.5 kg
  • Bag of 5 kg
  • Jar of 500 g
  • Jar of 1 kg
  • Bag of 500 g

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • CEVA Sante Animale B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Ceva Sante Animale
  • Laboratoires Biove
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 115721
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0285/001

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 6/04/2022
Download